Rachel Bender Ignacio

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with University of Washington, Fred Hutch Cancer Center

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 39 papers. Top paper: “Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection”.

Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection

Annals of Internal Medicine(2023)10.7326/m22-2381

N/A

2.0DataRank · unranked

63 citations

Manish C. Choudhary, Carlee Moser, Justin Ritz, Eric S. Daar, David A. Wohl +41 more

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01254-1

N/A

1.6DataRank · unranked

53 citations

Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain +51 more

Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2706

N/A

1.2DataRank · unranked

14 citations

David A. Wohl, Rosalin Arends, Venkatesh Pilla Reddy, Ying Mu, Arzhang Cyrus Javan +8 more

Modernizing the Data Infrastructure for Clinical Research to Meet Evolving Demands for Evidence

JAMA(2024)10.1001/jama.2024.0268

N/A

0.940DataRank · unranked

25 citations

Caroline Marra, Atul Janardhan Butte, Laura Esserman, Lee A. Fleisher, Cynthia I. Grossman +64 more

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

Annals of Internal Medicine(2023)10.7326/m22-3428

N/A

0.785DataRank · unranked

31 citations

Kara W Chew, Mark J Giganti, Carlee Moser, Mauricio Pinilla, David A. Wohl +76 more

The Integration of Clinical Trials With the Practice of Medicine

JAMA(2024)10.1001/jama.2024.4088

N/A

0.646DataRank · unranked

73 citations

Alison J. Huang, Roger J. Lewis, Amy P. Abernethy, Robert M. Califf, Martin Landray +63 more

One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad342

N/A

0.622DataRank · unranked

19 citations

Kara W Chew, Mark J Giganti, Eric S. Daar, David A. Wohl, Arzhang Cyrus Javan +47 more

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102250

N/A

0.587DataRank · unranked

12 citations

Kara W Chew, Mark J Giganti, Michael D. Hughes, Carlee Moser, Mark Main +79 more

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.10039

N/A

0.490DataRank · unranked

11 citations

Kara W Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan +47 more

Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials

(2023)10.1093/infdis/jiad285

N/A

0.475DataRank · unranked

7 citations

Kara W Chew, Mark J Giganti, Jonathan Z. Li, Evgenia Aga, Justin Ritz +24 more

Dynamic immune markers predict HIV acquisition and augment associations with sociobehavioral factors for HIV exposure

iScience(2022)10.1016/j.isci.2022.105632

N/A

0.292DataRank · unranked

6 citations

Sayan Dasgupta, Rogelio Valdez, Urvashi Pandey, Siavash Pasalar, Ricardo Alfaro +5 more

Characterizing HIV status documentation among cancer patients at regional cancer centers in Malawi, Zimbabwe, and South Africa

Infectious Agents and Cancer(2023)10.1186/s13027-023-00548-1

N/A

0.208DataRank · unranked

3 citations

Takudzwa J. Mtisi, Ntokozo Ndlovu, Margaret Borok, Agatha Bula, Maureen Joffe +3 more

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102787

N/A

0.208DataRank · unranked

3 citations

Carlee Moser, Nikolaus Jilg, Justin Ritz, David A. Wohl, Jonathan Z. Li +89 more

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae369

N/A

0.165DataRank · unranked

2 citations

Babafemi Taiwo, Carlee Moser, Eric S. Daar, David A. Wohl, Justin Ritz +46 more

Observational study of effects of HIV Acquisition and Antiretroviral Treatment on Biomarkers of Systemic Immune Activation

medRxiv(2023)10.1101/2023.07.07.23292352

N/A

0.165DataRank · unranked

2 citations

Jackson Wallner, Ana Gervassi, Rachel Bender Ignacio, Delia Pinto-Santini, Germán G. Gornalusse +7 more

Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C

Clinical Infectious Diseases(2025)10.1093/cid/ciaf305

N/A

0.104DataRank · unranked

1 citations

Min‐Hee Kang, Triin Umbleja, Estêvão Portela Nunes, Kristen Marks, Anne F. Luetkemeyer +67 more

Healthcare provider perspectives on integrating HIV care into cancer centers in Malawi, South Africa, Uganda, and Zimbabwe

Translational Oncology(2025)10.1016/j.tranon.2025.102273

N/A

0.104DataRank · unranked

1 citations

Alfred Jatho, Cecilia Nassolo, Noleb M. Mugisha, Agatha Bula, Maganizo Chagomerana +6 more

Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

iScience(2025)10.1016/j.isci.2025.111938

N/A

0.104DataRank · unranked

1 citations

Kara W Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan +14 more

Immune Activation in Primary Human Immunodeficiency Virus: Influence of Duration of Infection, Treatment, and Substance Use

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac155

N/A

0.104DataRank · unranked

1 citations

Samuel R Schnittman, Edward White, Jacqueline Mercader, Yixin Wang, Sayan Dasgupta +9 more

Characterizing HIV status documentation among cancer patients at regional cancer centers in Malawi, Zimbabwe, and South Africa

medRxiv(2023)10.1101/2023.09.04.23294963

N/A

0.104DataRank · unranked

1 citations

Takudzwa J. Mtisi, Ntokozo Ndlovu, Margaret Borok, Agatha Bula, Maureen Joffe +3 more

A phase 1b/pharmacokinetic trial of PTC299, a novel post-transcriptional VEGF inhibitor, for AIDS-related Kaposi’s sarcoma: AIDS Malignancy Consortium trial 059

UNC Libraries(2020)10.17615/q862-w217

N/A

0DataRank · unranked

1 citations

Anil Tulpule, Bruce J. Dezube, Dirk P. Dittmer, Rachel Bender Ignacio, Veenadhari Chavakula +13 more

Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials

medRxiv(2023)10.1101/2023.03.13.23287208

N/A

0DataRank · unranked

2 citations

Kara W Chew, Mark J Giganti, Jonathan Z. Li, Evgenia Aga, Justin Ritz +10 more

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19

UNC Libraries(2023)10.17615/vptt-dg28

N/A

0DataRank · unranked

0 citations

Arzhang Cyrus Javan, Joseph J. Eron, Justin Ritz, Judith S. Currier, Prasanna Jagannathan +12 more

Protocol for evaluating mechanistic pathways associated with HIV acquisition via nested Least Absolute Shrinkage and Selective Operator analysis

STAR Protocols(2023)10.1016/j.xpro.2023.102628

N/A

0DataRank · unranked

0 citations

Angela K. Ulrich, Ann Duerr, Rachel Bender Ignacio, Sayan Dasgupta

Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition

PLoS ONE(2022)10.1371/journal.pone.0267729

N/A

0DataRank · unranked

4 citations

Jessica E. Long, Aparajita Saha, Felicia K. Nguyen, Lara L. Joudeh, Ethan Valinetz +10 more

Genetic and environmental imprints on T cell receptor repertoires as predictors of graft-versus-host disease

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.23.696252

N/A

0DataRank · unranked

0 citations

Zachary Montague, Magdalena L Russell, Rachel Bender Ignacio, Terry Stevens-Ayers, Danniel Zamora +5 more

Observational study of effects of HIV acquisition and antiretroviral treatment on biomarkers of systemic immune activation

PLoS ONE(2024)10.1371/journal.pone.0288895

N/A

0DataRank · unranked

7 citations

Jackson Wallner, Ana Gervassi, Rachel Bender Ignacio, Delia Pinto-Santini, Germán G. Gornalusse +7 more

An urgent call to address the intersection of mpox and HIV in Africa

The Lancet(2024)10.1016/s0140-6736(24)02542-x

N/A

0DataRank · unranked

4 citations

Adrienne E. Shapiro, Michalina A. Montaño, Boghuma K Titanji, Rachel Bender Ignacio

Viral and Symptom Rebound Following Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae501

N/A

0DataRank · unranked

0 citations

Brooke McGinley, Carlee Moser, Jonathan Z. Li, Teresa H. Evering, Justin Ritz +42 more

Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic Enhancement

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf319

N/A

0DataRank · unranked

1 citations

Charles Flexner, Zachary R. Stephen, Edward P. Acosta, Rachel Bender Ignacio, Rodney J. Y. Ho +1 more

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf542

N/A

0DataRank · unranked

1 citations

Manish C. Choudhary, Owen T. Glover, Rachel Bender Ignacio, Julie Boucau, Kara W Chew +21 more

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

UNC Libraries(2025)10.17615/ryrv-wq75

N/A

0DataRank · unranked

0 citations

Yan Li, Jonathan Z. Li, Rachel Bender Ignacio, Kara W Chew, Bharat Mocherla +23 more

Association of Tecovirimat Therapy With Mpox Symptom Improvement: A Cross-sectional Study—King County, Washington, May–October 2022

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae029

N/A

0DataRank · unranked

16 citations

Matthew R. Golden, Roxanne P. Kerani, Sargis Pogosjans, Eric J. Chow, Rachel Bender Ignacio +5 more

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac618

N/A

0DataRank · unranked

14 citations

Jonathan Z. Li, Joseph J. Eron, Evgenia Aga, Eric S. Daar, David A. Wohl +29 more

Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition

medRxiv(2021)10.1101/2021.12.08.21267470

N/A

0DataRank · unranked

1 citations

Jessica E. Long, Aparajita Saha, Felicia K. Nguyen, Lara L. Joudeh, Ethan Valinetz +10 more

Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis

Epidemiology and Infection(2021)10.1017/s0950268821000571

N/A

0DataRank · unranked

20 citations

Pingping Qu, Michael Boeckh, Rachel Bender Ignacio, Sahar Z. Zangeneh, Chikara Ogimi

Acute retroviral syndrome is associated with lower CD4+ T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiation

AIDS(2023)10.1097/qad.0000000000003511

N/A

0DataRank · unranked

11 citations

Javier R. Lama, Rogelio Valdez, Sayan Dasgupta, Robinson Cabello, Hugo Sánchez +8 more

Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses

mBio(2021)10.1128/mbio.03347-21

N/A

0DataRank · unranked

70 citations

Joshua T. Schiffer, Rachel Bender Ignacio, Shuang Xu, Denis E. Kainov, Aleksandr Ianevski +5 more

Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study

The Lancet Microbe(2021)10.1016/s2666-5247(21)00010-0

N/A

0DataRank · unranked

71 citations

Rachel Bender Ignacio, Javier R. Lama, Amélie Pagliuzza, Sayan Dasgupta, Ricardo Alfaro +7 more